MURAL - Maynooth University Research Archive Library

    Investigation of efficacy and mechanisms of action in mesenchymal stromal cell therapy for chronic lung diseases

    Kennelly, Helen (2015) Investigation of efficacy and mechanisms of action in mesenchymal stromal cell therapy for chronic lung diseases. PhD thesis, National University of Ireland Maynooth.

    Download (433MB) | Preview

    Share your research

    Twitter Facebook LinkedIn GooglePlus Email more...

    Add this article to your Mendeley library


    Mesenchymal Stromal Cells (MSC) are adult multipotent cells that possess self-­‐renewal and regenerative capacities, with the ability to differentiate into a variety of cell types. They have potent immunosuppressive abilities, facilitating the use of allogeneic MSC as a cellular therapy. Functionally, it is the trophic mediated effects of MSC that have become the focus of research due to paracrine mediated tissue reparative and protective effects. This study has examined the use of MSC for the treatment of inflammatory and fibrotic lung diseases, specifically Chronic Obstructive Pulmonary Disease (COPD) and Idiopathic Pulmonary Fibrosis (IPF). In vitro characterisation of MSC demonstrated significant cytoprotective and reparative effects, through inhibition of epithelial apoptosis, suppression of neutrophil functions and repair of injured epithelial cells. These effects were mediated by MSC production of HGF and subsequent paracrine signalling. Utilising a humanised mouse model of COPD, MSC administration resulted in beneficial cytoprotective effects due to HGF, including reduced inflammation, and epithelial apoptosis. These effects were greatest with early MSC administration with reduced efficacy following late MSC administration. In a bleomycin mouse model of fibrosis, MSC again displayed significant cytoprotective effects with early MSC intervention. Decreased epithelial apoptosis and collagen deposition were observed with MSC treatment with HGF demonstrated to be important in this process. The work presented here demonstrates significant protective effects of early MSC treatment in inflammatory and fibrotic lung diseases mediated in part by MSC production of HGF.

    Item Type: Thesis (PhD)
    Keywords: Investigation; efficacy; mechanisms; action; mesenchymal stromal cell therapy; chronic lung diseases;
    Academic Unit: Faculty of Science and Engineering > Biology
    Faculty of Science and Engineering > Research Institutes > Institute of Immunology
    Item ID: 10372
    Depositing User: IR eTheses
    Date Deposited: 04 Jan 2019 16:23
      Use Licence: This item is available under a Creative Commons Attribution Non Commercial Share Alike Licence (CC BY-NC-SA). Details of this licence are available here

      Repository Staff Only(login required)

      View Item Item control page


      Downloads per month over past year

      Origin of downloads